Michal Sheffer

5.4k total citations · 1 hit paper
31 papers, 2.4k citations indexed

About

Michal Sheffer is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Michal Sheffer has authored 31 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 8 papers in Hematology and 8 papers in Cancer Research. Recurrent topics in Michal Sheffer's work include Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (6 papers) and Immune Cell Function and Interaction (5 papers). Michal Sheffer is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (6 papers) and Immune Cell Function and Interaction (5 papers). Michal Sheffer collaborates with scholars based in United States, Israel and Finland. Michal Sheffer's co-authors include Eytan Domany, Uri Alon, Inbal Ayzenshtat, Shalev Itzkovitz, Nadav Kashtan, Shai S. Shen-Orr, Ron Milo, Yotam Drier, Francis Barany and Daniel A. Notterman and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Michal Sheffer

29 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Superfamilies of Evolved and Designed Networks

2004 962 citations Michal Sheffer et al. profile →

Peers

Countries citing papers authored by Michal Sheffer

Since Specialization

Citations

This map shows the geographic impact of Michal Sheffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Sheffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Sheffer more than expected).

Fields of papers citing papers by Michal Sheffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Sheffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Sheffer. The network helps show where Michal Sheffer may publish in the future.

Co-authorship network of co-authors of Michal Sheffer

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Sheffer. A scholar is included among the top collaborators of Michal Sheffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Sheffer. Michal Sheffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An innovative single-cell approach for phenotyping and functional genotyping of CAR NK cells 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), (unknown), (unknown), Alaa Kassim Ali, (unknown), (unknown), (unknown), Michal Sheffer, Rizwan Romee, Tania Konry	4
2	Mesothelin Targeting IL12-Engineered CAR Memory-like NK Cells Demonstrate Promising Efficacy in Acute Myeloid Leukemia 2024 ·Blood ·Ji Eun Jang, Maja Stanojević, (unknown), Michal Sheffer, (unknown), Roman M. Shapiro, Maximilian Stahl, John Koreth, Catherine J. Wu, Robert J. Soiffer, Jerome Ritz, Mubin Tarannum, Rizwan Romee	4
3	Functional Genomic Landscape of Natural Killer Cell Evasion in Multiple Myeloma 2021 ·Blood ·Sara Gandolfi, Olli Dufva, Jani Huuhtanen, Olga Dashevsky, Jay Klievink, (unknown), Michal Sheffer, Matti Kankainen, Ricardo De Matos Simoes, Satu Mustjoki, Constantine S. Mitsiades	2
4	Functional Genomic and Immune Response Characterization of PTEN Loss: Therapeutic Implications for Myeloma 2021 ·Blood ·Olga Dashevsky, Ricardo De Matos Simoes, Benjamin G. Barwick, Sara Gandolfi, Ryosuke Shirasaki, Michal Sheffer, Aedín C. Culhane, Richard W.J. Groen, Aviad Tsherniak, Francisca Vázquez, Jonathan D. Licht, Lawrence Boise, Constantine S. Mitsiades	0
5	Use of Olfactory Receptor Genes As Controls for Genome-Scale CRISPR Functional Genomic Studies to Define Treatment Resistance Mechanisms 2020 ·Blood ·Olga Dashevsky, Ricardo De Matos Simoes, Ryosuke Shirasaki, Michal Sheffer, Eugen Dhimolea, Sara Gandolfi, Huihui Tang, Sondra L. Downey-Kopyscinski, (unknown), (unknown), Brian Glassner, John G. Doench, (unknown), Jonathan D. Licht, Aedín C. Culhane, William C. Hahn, Francisca Vázquez, Aviad Tsherniak, Constantine S. Mitsiades	0
6	Molecular markers of MM cell sensitivity and resistance to Natural Killer cells: implications for anti-MM immunotherapy 2019 ·Clinical Lymphoma Myeloma & Leukemia ·Sara Gandolfi, Michal Sheffer, (unknown), Olga Dashevsky, Ryosuke Shirasaki, Ricardo De Matos Simoes, Rizwan Romee, Jennifer A. Roth, Constantine S. Mitsiades	1
7	CRISPR Screens Identify Mechanisms of Natural Killer Cell Evasion across Blood Cancers 2019 ·Blood ·Olli Dufva, Khalid Saeed, Sara Gandolfi, Michal Sheffer, Jay Klievink, Petri Pölönen, Tiina Hannunen, Mette Ilander, Pekka Ellonen, Matti Kankainen, Dean A. Lee, Constantine S. Mitsiades, Satu Mustjoki	3
8	CRISPR Activation Screen for HDAC Inhibitor Resistance 2018 ·Blood ·Huihui Tang, Ricardo De Matos Simoes, Ryosuke Shirasaki, Olga Dashevsky, Brian Glassner, Sondra L. Downey-Kopyscinski, Sara Gandolfi, Michal Sheffer, (unknown), John G. Doench, Constantine S. Mitsiades	1
9	Long-Term Interactions with Bone Marrow Stromal Cells Alter the Molecular Dependencies of Myeloma Cells: Insights from Genomewide CRISPR-Based Functional Genomic Screens 2017 ·Blood ·Sara Gandolfi, Olga Dashevsky, Ricardo De Matos Simoes, Geoffrey M. Matthews, Ryosuke Shirasaki, Michal Sheffer, Constantine S. Mitsiades	1
10	Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation 2016 ·Cell Metabolism ·Noga Ron‐Harel, Daniel Santos, Jonathan M. Ghergurovich, Peter T. Sage, Anita Reddy, Scott B. Lovitch, Noah Dephoure, F. Kyle Satterstrom, Michal Sheffer, Jessica B. Spinelli, Steven P. Gygi, Joshua D. Rabinowitz, Arlene H. Sharpe, Marcia C. Haigis	301
11	NF-κB dysregulation in multiple myeloma 2016 ·Seminars in Cancer Biology ·Geoffrey M. Matthews, Ricardo De Matos Simoes, Eugen Dhimolea, Michal Sheffer, Sara Gandolfi, Olga Dashevsky, (unknown), Constantine S. Mitsiades	43
12	BET Bromodomain Degradation As a Therapeutic Strategy in Multiple Myeloma 2016 ·Blood ·Geoffrey M. Matthews, Sara Gandolfi, (unknown), Ricardo De Matos Simoes, Dennis L. Buckley, Yiguo Hu, Michal Sheffer, (unknown), James E. Bradner, Constantine S. Mitsiades	3
13	Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival 2016 ·Proceedings of the National Academy of Sciences ·Débora Rosa Bublik, Slađana Bursać, Michal Sheffer, Ines Oršolić, Tali Shalit, Ohad Tarcic, Eran Kotler, (unknown), (unknown), Gilad Fuchs, Yishai Levin, Siniša Volarević, Moshe Oren	55
14	HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways 2013 ·Cancer Letters ·Sun-Hee Kim, Dingzhi Wang, Yun‐Yong Park, Hiroshi Katoh, Ofer Margalit, Michal Sheffer, Hong Wu, Vijaykumar Holla, Ju‐Seog Lee, Raymond N. DuBois	21
15	Pathway-based personalized analysis of cancer 2013 ·Proceedings of the National Academy of Sciences ·Yotam Drier, Michal Sheffer, Eytan Domany	232
16	HIPK2 downregulates vimentin and inhibits breast cancer cell invasion 2012 ·Cancer Biology & Therapy ·(unknown), Michal Sheffer, Jasmine Jacob‐Hirsch, Valentina Folgiero, Rita Falcioni, Aurora Aiello, Alessia Garufi, Gideon Rechavi, David Givol, Gabriella D’Orazi	30
17	Gene Expression following Exposure to Celecoxib in Humans: Pathways of Inflammation and Carcinogenesis Are Activated in Tumors but Not Normal Tissues 2011 ·Digestion ·Eyal Sagiv, Michal Sheffer, Diana Kazanov, Shiran Shapira, (unknown), Sarah Kraus, Eytan Domany, Nadir Arber	3
18	S1971 Celecoxib Selectively Targets Genes and Pathways Involved in Inflammation and Malignant Transformation in Tumor But Not Normal Cells 2009 ·Gastroenterology ·Eyal Sagiv, Michal Sheffer, Diana Kazanov, Shiran Shapira, (unknown), Sarah Kraus, Eytan Domany, Nadir Arber	1
19	Expression of L1-CAM and ADAM10 in Human Colon Cancer Cells Induces Metastasis 2007 ·Cancer Research ·Nancy Gavert, Michal Sheffer, Shani Raveh, Simone Spaderna, Michael Shtutman, Thomas Brabletz, Francis Barany, Phillip Paty, Daniel A. Notterman, Eytan Domany, Avri Ben‐Ze'ev	167
20	Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma 2005 ·Oncogene ·Christophe Rosty, Michal Sheffer, Dafna Tsafrir, Nicolas Stransky, Ilan Tsafrir, Martine Peter, Patricia de Crémoux, Anne de la Rochefordière, Rémy Salmon, Thierry Dorval, Jean Paul Thiery, Jérôme Couturier, François Radvanyi, Eytan Domany, Xavier Sastre‐Garau	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact